K8Y-25232-17877
2 vaccinations
3 coded responses
22 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 551 / MN
- Registered
- 2020-12-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2020-12-24
Registered in v-safe
- 2020-12-24
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2021-01-06
-
2021-01-11
Dose 2 — Pfizer-BioNTech
-
2021-01-11
Survey response — day 0, dose 2MedDRA: Pregnancy — Feeling: Good · Site: Pain, SwellingFree text: Currently 16 weeks pregnantMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-25
- 2021-02-01
- 2021-02-08
- 2021-02-15
-
2021-02-15
Call successfulDoes not wish to fill out VAERS report
- 2021-02-24
- 2021-04-12
-
2021-07-12
Survey response — 6 months, dose 2MedDRA: Pre-eclampsia — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: PreeclampsiaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-12
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-29
-
2021-07-29
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-01-11
Survey response — 12 months, dose 2MedDRA: Diarrhoea, Gastroenteritis viral, Nausea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Nausea and diarrhea from stomach flu last weekMedDRA releases: 2024-11 · check-in free text available
-
2022-01-11
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-01-14
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech |
Call center
3 call center cases
3 successful
Free text
Release 1 — day 0, dose 2
Systemic reaction (other): Currently 16 weeks pregnant
Release 9 — 6 months, dose 2
Symptoms: Preeclampsia
Release 10 — 12 months, dose 2
Symptoms: Nausea and diarrhea from stomach flu last week
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | · | · | ✓ |
| SD | Gastroenteritis viral | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pre-eclampsia | ✓ | ✓ | ✓ |
| SRO | Exposure during pregnancy | ○ | ○ | ○ |
| SRO | Pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release